IMMUNIC, INC.
IMUX$83M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEW YORK
Drugs in Pipeline
3
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 6, 2026
6wMarket Overview
Stock performance and key metrics
IMUX News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
IMU-838 tablets
Multiple Sclerosis, Relapsing-Remitting
IMU-838
Multiple Sclerosis
IMU-838 (30 mg/day)
Relapsing-Remitting Multiple Sclerosis (RRMS)
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
IMU-838 tablets | Phase 3 | Multiple Sclerosis, Relapsing-Remitting | - | - |
IMU-838 | Phase 3 | Multiple Sclerosis | - | - |
IMU-838 (30 mg/day) | Phase 2 | Relapsing-Remitting Multiple Sclerosis (RRMS) | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply